Psilocybin Therapy for Methamphetamine Use Disorder and HIV (NCT07756736)
Psilocybin Recovery Intervention for Stopping Methamphetamine Use
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn whether it is possible to use psilocybin in combination with motivational support therapy to treat moderate-to-severe methamphetamine use disorder (MeUD) in people with HIV who are seeking to stop using methamphetamine. The main questions it aims to answer are: * Do people with HIV and MeUD find psilocybin with motivational support therapy feasible and acceptable as a potential treatment? * Is psilocybin safe and tolerable among people with HIV and MeUD? Participants will: * Be randomly assigned to receive a single monitored dose of either 25 mg (higher dose) or 5 mg (lower dose) psilocybin * Have 3 preparation and 3 integration motivational support therapy visits before and after the psilocybin dosing session. * Report their methamphetamine use prior to, during, and up to 3 months following the intervention * Optionally receive one additional open-label 25 mg psilocybin session after the 4-week assessment, if eligible
Who can join: Review the eligibility criteria below.
Location: UCSF at Zuckerberg San Francisco General Hospital — San Francisco, California
Age range: 25 Years to 64 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UCSF at Zuckerberg San Francisco General Hospital — San Francisco, California
📞 Contact the Study Coordinator
Phone: (510) 985-3522
Email: prism.trial@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Methamphetamine Use Disorder
- Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder — Aurora, Colorado
- Psilocybin for Methamphetamine Use Disorder — Birmingham, Alabama
- Methamphetamine and Troriluzole — Lexington, Kentucky
- Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder — Aurora, Colorado
- Deep TMS of Neural Circuits Associated With Stimulant Use Disorder — Palo Alto, California
Explore by condition: All Methamphetamine Use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.